Form 4: Neuronetics Director Boosts Stake with $481K Stock Buy

Neuronetics Director and 10% owner Jorey Chernett acquired 385,442 shares of common stock for approximately $481,802 on March 30, 2026, increasing beneficial ownership to 9,778,988 shares.

Summary

• Jorey Chernett, a Director and 10% Owner of Neuronetics, Inc. (STIM), acquired 385,442 shares of common stock on March 30, 2026.
• The shares were purchased at a weighted average price of $1.25 per share, with individual transaction prices ranging from $1.23 to $1.26.
• The total value of this acquisition is approximately $481,802.50.
• Following this transaction, Mr. Chernett beneficially owns 9,778,988 shares of Neuronetics common stock.
• This filing also corrects a clerical error in a Form 4 previously filed on March 30, 2026, where the number of shares beneficially owned by Mr. Chernett was under-reported by 270 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal due to a significant insider purchase by a director and 10% owner, indicating confidence in the company's value.

Positives

• A Director and 10% owner increasing their stake can signal strong confidence in the company's future prospects.
• The acquisition of 385,442 shares represents a significant investment by an insider, totaling approximately $481,802.50.

Future Outlook

This Form 4 filing does not contain specific forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider purchases, especially by significant shareholders and directors, are often interpreted by the market as a positive signal, indicating management's belief in the company's undervalued stock or strong future prospects, potentially contrasting with broader industry sentiment or recent performance.

Comparison to Industry Standards

• This filing reports an insider transaction and does not provide financial results or operational metrics that can be directly compared to industry standards or specific competitor projects. The significance lies in the insider's conviction rather than performance benchmarks.

Related Party Transactions

• Jorey Chernett, a Director and 10% owner of Neuronetics, Inc., acquired common stock from the issuer.

Stakeholder Impact

• Shareholders: May view the insider purchase as a positive indicator of future stock performance and management's belief in the company's value.
• Management: The transaction reinforces alignment between a key insider and the company's equity performance, potentially boosting internal morale.

Next Steps

• The filing does not mention any specific future actions, events, or milestones beyond the transaction itself.

Key Dates

Recommendation

The significant purchase by a Director and 10% owner, Jorey Chernett, signals strong insider confidence in Neuronetics, Inc. This action suggests that a key stakeholder believes the stock is undervalued or has strong future potential. While a positive indicator, a 'hold' recommendation is appropriate as this single transaction, without further financial or operational updates, primarily reinforces conviction for existing shareholders rather than prompting new investment solely based on this filing.

Keywords

Neuronetics, STIM, Jorey Chernett, Insider Trading, Stock Purchase, Form 4, Director, 10% Owner, Common Stock, Beneficial Ownership